FORM OF LETTER AGREEMENTLetter Agreement • August 5th, 2019 • Amneal Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This letter agreement (this “Letter Agreement”) is to confirm the mutual understanding among Credit Suisse AG, acting through its New York Branch (the “Lender”), Amneal Pharmaceuticals LLC (the “Company”), Amneal Pharmaceuticals, Inc. (“Amneal”) and __________ (the “Borrower”) with respect to the pledge (the “Pledge”) by the Borrower to the Lender (itself or through one of its affiliates, any such affiliate being treated as the Lender for purposes of this Letter Agreement) of, initially, _________ Units of the Company (the “Units”) and an equal number of shares of Class B Common Stock of Amneal (the “Class B Shares”), in each case pursuant to a Promissory Note and Collateral Agreement dated as of ____________ between the Borrower and the Lender (as amended, supplemented or modified from time to time, the “Loan Agreement”) and certain transactions related thereto. The Pledge will be made in favor of the Lender (the Units and Class B Shares that are so pledged at any time, the “Pledged S
Amendment No. 1 to the Second Amended and Restated Stockholders AgreementStockholders Agreement • August 5th, 2019 • Amneal Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Amendment No. 1 (this “Amendment”) to the Second Amended and Restated Stockholders Agreement dated as of December 16, 2017 (the “Agreement”), by and among Amneal Pharmaceuticals Holding Company, LLC, a Delaware limited liability company, AP Class D Member, LLC, a Delaware limited liability company, AP Class E Member, LLC, a Delaware limited liability company, AH PPU Management, LLC, a Delaware limited liability company, and Amneal Pharmaceuticals, Inc. (which was previously known as Atlas Holdings, Inc.), a Delaware corporation, is entered into as of this 2nd day of August, 2019. Capitalized terms used in this Amendment and not otherwise defined shall have the meanings ascribed to them in the Agreement.
SEPARATION AGREEMENTSeparation Agreement • August 5th, 2019 • Amneal Pharmaceuticals, Inc. • Pharmaceutical preparations • Florida
This Separation Agreement (“Separation Agreement”) is entered into between Robert Stewart (“Executive”) and Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals, Inc. (f/k/a Atlas Holdings, Inc.) (collectively “Amneal” or the “Company”) as of August 2, 2019 (the “Effective Date”). Capitalized terms not otherwise defined herein shall have the meanings set forth in that certain Employment Agreement between Executive and the Company entered into as of December 16, 2017 (“Employment Agreement”) as amended from time to time.
FORM OF ACKNOWLEDGMENT AND AGREEMENTAcknowledgment and Agreement • August 5th, 2019 • Amneal Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Acknowledgment and Agreement (this “Agreement”) is made as of _________, by and among ________________ (“Pledgor”), AMNEAL PHARMACEUTICALS LLC, a Delaware limited liability corporation (the “LLC”), AMNEAL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and MORGAN STANLEY PRIVATE BANK, NATIONAL ASSOCIATION (“Lender”).
